We recently described an uncommon subset of SCLC with RB1 proficiency, characterized by expression of wild-type RB1 in tumors that otherwise exhibited classic properties of SCLC, including TP53 mutations, high TMB, and history of smoking. This evidence concerns the gene TP53 and small cell lung carcinoma.